Key facts
- ClearCut Surgical’s last known valuation is $7.7M (Jan 2026).
- It has raised $6.5M across 1 recorded rounds; the latest was Seed Round ($4.5M) in Jun 2025.
- Notable investors include MedTech Innovator, MassVentures, Launchpad Venture Group, General Inception, Angel Investor Forum — 8 tracked in total.
- ClearCut Surgical has filed 1 Form D with the SEC, most recently Aug 2025 ($2.3M sold to 34 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for ClearCut Surgical
Funding rounds
1 roundsAbout ClearCut Surgical
Developer of a surgical medical device designed to identify and solve problems that practicing surgeons face every day. The company offers an injection-molded plastic device that does not require additional electric power, which combines electrocautery, continuous smoke evacuation, and on-demand fluid suction, enabling doctors and surgical teams to switch functions with a pneumatic piston that connects to the vacuum suction in the wall of the operating room.
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2022
- Employees
- 9
- Website
- clearcutsurgical.com/
- Ownership
- Privately Held (backing)
ClearCut Surgical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ClearCut Surgical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ClearCut Surgical in its N-PORT filings yet. We sweep new filings monthly.